Valuation PTC Therapeutics, Inc. Berne S.E.

Stocks

Delayed Berne S.E.			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-

09-15	PTC Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 09:15 AM
08-24	Ptc Therapeutics Announces New Sephience Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as Well as Consistent Favorable Safety Profile	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,816	2,786	2,080	3,481	6,099	5,198	-	-
Change	-	-1.06%	-25.35%	67.4%	75.18%	-14.77%	-	-
Enterprise Value (EV) ¹	2,474	2,947	1,487	2,627	4,440	3,327	3,053	3,327
Change	-	19.12%	-49.54%	76.65%	69%	-25.07%	-8.24%	8.99%
P/E	-5.36x	-4.9x	-3.29x	-9.54x	9.76x	40x	21.8x	16.4x
PBR	1,952x	-7.89x	-2.55x	-3.19x	-30.1x	-46.2x	30.6x	8.29x
PEG	-	-1.01x	-0.44x	0.2x	-0x	-0.5x	0.3x	0.5x
Capitalization / Revenue	5.23x	3.99x	2.22x	4.32x	3.52x	4.13x	3.78x	3.24x
EV / Revenue	4.59x	4.22x	1.59x	3.26x	2.57x	2.64x	2.22x	2.08x
EV / EBITDA	-7.97x	-9.25x	-7.33x	-11.6x	4.9x	8.08x	5.61x	4.83x
EV / EBIT	-6.61x	-6.59x	-3.38x	-8.68x	5.12x	9.41x	6.43x	5.49x
EV / FCF	-8.85x	-7.58x	-7.96x	-23x	6.32x	-256x	49.2x	15.1x
FCF Yield	-11.3%	-13.2%	-12.6%	-4.35%	15.8%	-0.39%	2.03%	6.63%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.43	-7.79	-8.37	-4.73	7.78	1.557	2.857	3.788
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	538.6	698.8	937.8	806.8	1,731	1,258	1,377	1,602
EBITDA ¹	-310.3	-318.6	-202.9	-226.9	905.8	411.6	544.5	689.3
EBIT ¹	-374.4	-447.4	-439.5	-302.6	866.9	353.7	474.8	605.6
Net income ¹	-523.9	-559	-626.6	-363.3	682.6	145.4	231.5	344.6
Net Debt ¹	-341.9	161	-592.5	-854.3	-1,659	-1,871	-2,145	-1,871
Reference price ²	39.83	38.17	27.56	45.14	75.96	62.28	62.28	62.28
Nbr of stocks (in thousands)	70,698	72,991	75,463	77,125	80,288	83,461	-	-
Announcement Date	22/02/22	21/02/23	29/02/24	27/02/25	19/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.6x	12.18x	24.75x	0.59%	1,053B
JOHNSON & JOHNSON	30.11x	6.7x	18.74x	1.98%	652B
ABBVIE INC.	33.53x	7.84x	16.21x	2.59%	468B
ROCHE HOLDING AG	19.76x	4.82x	11.93x	2.75%	351B
NOVARTIS AG	20.25x	5.27x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.9x	4.34x	12.34x	2.04%	254B
AMGEN INC.	25.65x	6.7x	11.94x	2.48%	220B
GILEAD SCIENCES, INC.	-45.27x	6.59x	25.75x	2.2%	186B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	170B
Average	16.65x	6.51x	15.92x	2.46%	403.04B
Weighted average by Cap.	24.17x	7.86x	18.10x	1.97%